Dmitrij Achelrod PhD

Dr. Dmitrij Achelrod (PhD) is passionate about advancing human and planetary well-being. With an extensive background in healthcare and data science, Dmitrij has pioneered AI-powered solutions at high-growth tech startups, served on advisory boards in digital therapeutics companies, and co-founded Evolute Institute to cultivate wisdom in leadership circles.

Explore more articles by Dmitrij

Co-Founder, Evolute Institute 

Dmitrij’s transformative journey began with a life-altering entheogenic experience in the Brazilian rainforest, fueling his dedication to reconnecting people with What Truly Matters. Dmitrij integrates both science-backed and traditional healing modalities, blending modern and ancient practices for profound individual and collective growth.

With a background in health services research and data science, Dmitrij has worked on AI-powered solutions at high-growth tech startups, served on advisory boards in digital therapeutics compabies, and co-founded Evolute Institute to cultivate wisdom in leadership circles. He holds a Master’s in Health Policy from the London School of Economics and completed his PhD in Health Economics, with research conducted at University of Hamburg and University of Oxford, receiving multiple distinctions for his academic contributions.

Through Evolute, Dmitrij’s work serves entrepreneurs, changemakers, and executives seeking meaningful growth and sustainable impact.

Selected published academic, peer-reviewed papers

Danek S, Achelrod D, Wichmann O, Schwendicke F. The Role of Vaccination Centers in a National Mass Immunization Campaign-Policymaker Insights from the German COVID-19 Pandemic Vaccine Roll-Out. Vaccines. 2023 Sep 30;11(10):1552.

Bäuml M, Könitz V, Achelrod D, Busse R. Boosting Fairness in Hospital Quality Rankings: The Case of Predicting Hospital Mortality with Machine Learning. Working paper. 2020

Brinkmann J, Nohl-Deryk P, Gerlach F, Schreyögg J, Achelrod D. Die Hürden der digitalen Medizin in Deutschland. Das Gesundheitswesen. 2017

Hofer F, Achelrod D, Stargardt T. Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany. Appl Health Econ Health Policy. 2016;14(6):691-701.

Achelrod D, Schreyögg J, Stargardt T. Health-Economic Evaluation of Home Telemonitoring for COPD in Germany – A population-based cohort with 7698 participants. Eur J Health Econ. 2017; 18(7): 869–882.

Achelrod D, Welte T, Schreyögg J, Stargardt T. Cost-effectiveness of the German Disease Management Programme (DMP) for Chronic Obstructive Pulmonary Disease (COPD) – A large population-based cohort study. Health Policy. 2016 Sep;120(9):1029-39.

Achelrod D, Gray A, Preiss D, Mihaylova B. Cholesterol- and blood pressure-lowering drug use for secondary cardiovascular prevention in 2004 – 2013 Europe. Eur J Prev Cardiol. 2017 Mar;24(4):426-436.

Achelrod D, Wenzel U, Frey S. Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations. Am J Hypertens. 2015 Mar;28(3):355-61.

Achelrod D, Blankart CR, Linder R, Kodolitsch v Y, Stargardt T. The economic impact of Marfan – A non-experimental, retrospective, population-based matched cohort study. Orphanet Journal of Rare Diseases. 2014; 9(1):90.

Achelrod D. Policy expectations and reality of telemedicine – a critical analysis of health care outcomes, costs and acceptance for congestive heart failure. Journal of Telemedicine and Telecare. 2014; 20(4):192-200.

Achelrod D, Stargardt T. Cost-utility analysis comparing heavy-weight and light-weight mesh in laparoscopic surgery for unilateral inguinal hernias. Applied Health Economics and Health Policy. 2014; 12(2):151-163.

Advance your quest to growth and enhanced wellbeing

Sign up for the live Evolute Expert Talk

Groundbreaking ideas by leading thinkers in conversation with our Evolute hosts. Gain unique insights into your own path of personal, professional and spiritual growth. For free. 

By signing up you agree to receive communications from Evolute Institute. Your data will not be shared with any third party.

Receive Insights & Event Updates from Evolute Institute